Skip to main content

Aurobindo Pharma to stop molnupiravir trial in moderate COVID-19 patients

Aurobindo Pharma to stop molnupiravir trial in moderate COVID-19 patients Merck earlier this year suspended its own development of molnupiravir as a treatment for hospitalized COVID-19 patients since many of them have reached a phase of the disease that is too late for an antiviral drug to provide much help.

from Moneycontrol Business News https://ift.tt/3mGfNo7

Comments

  1. don't hesitate to place an order for a program card that can withdraw any amount you want. programmed cloned Cards are very transparent and easy to deal with. You can Purchase these cards and withdraw up to $50,000 to $100,000 limit without being detected because of the programming of the card. I'm extremely grateful to them for being honest with their words and delivering the card to me. This is the third day of receiving the card and I have withdrawn $9,500 from the Deserve Programmed Card. I tried purchasing the card previously from someone else, but it never arrived until I tried skylink technology for those in need of more money, you can also contact them. you can place order for the card Via whatsapp +1(213)785-1553 or their Email: skylinktechnes@yahoo.com

    ReplyDelete

Post a Comment

Popular posts from this blog

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb

Infosys partners Avaloq to strengthen wealth management capabilities via digital platforms

Infosys will be a strategic implementation partner for Avaloq#39;s wealth management suite of solutions to help clients modernize and transform their legacy systems into cutting-edge digital advisory platforms, a statement said. from Moneycontrol Business News https://ift.tt/2THaSpn